Limitation of Restrictions. Idenix acknowledges that Novartis is in the business of developing, manufacturing and selling medical processes and products and, subject to the specific provisions of this Agreement (including, without limitation, Sections 2.1, 5.3 and 5.15), nothing in this Agreement shall be construed as restricting such business or imposing on Novartis a duty to market and/or sell and exploit the Products to the exclusion of, or in preference to, any other product or process, or in any way other than in accordance with its normal commercial practices.
Appears in 2 contracts
Sources: Development, License and Commercialization Agreement (Idenix Pharmaceuticals Inc), Development, License and Commercialization Agreement (Idenix Pharmaceuticals Inc)